Skip to content
Events

Details

Illumina introduces a revolutionary next-generation sequencing (NGS) and multiomics technology—engineered to deliver deeper insights, accelerate discovery, and push the boundaries of what’s possible in genomics.

Jacob Thaysen

Opening and closing remarks
Jacob Thaysen, PhD
CEO
Illumina

Sergio Peisajovich

Platforms as our foundation
Sergio Peisajovich, PhD
VP, Head of Protein Engineering & Molecular Sciences R&D
Illumina

Cande Rogert

Redefining multiomics
Cande Rogert, PhD
VP, Global Head of Advanced Sciences
Illumina

Register here to watch this webinar on demand.

Your email address is never shared with third parties.

Date & Time
Feb 24, 2025
Topic
Instruments, Sequencing reagents & flow cells, Software & informatics
Watch Now

Related Events

Mar 23
ABRF Annual Meeting 2025
Mar 23, 2025 – Mar 26, 2025
Visit Illumina booth #200/202 at ABRF to network and learn more about our sequencing instruments, arrays, product releases, and trade-in offers. ​ ​
View Event
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see www.illumina.com/company/legal.html.

© 2025 Illumina, Inc. All rights reserved.